83 related articles for article (PubMed ID: 10203038)
1. The role of HIV gp120 in the disruption of the immune system.
Dalgleish AG; Marriott JB; Souberbielle B; Montesano C; Sheikh J; Sidebottom D; Westby M; Austen B
Immunol Lett; 1999 Mar; 66(1-3):81-7. PubMed ID: 10203038
[TBL] [Abstract][Full Text] [Related]
2. HIV gp120 plus specific peptides are recognized in a similar manner to specific HLA plus peptide by HLA-restricted antigen-specific T-cell lines.
Sheikh J; Souberbielle B; Westby M; Austen B; Dalgleish AG
Viral Immunol; 2000; 13(1):9-17. PubMed ID: 10733164
[TBL] [Abstract][Full Text] [Related]
3. The orientation of HIV-1 gp120 binding to the CD4 receptor differentially modulates CD4+ T cell activation.
Zimmermann K; Liechti T; Haas A; Rehr M; Trkola A; Günthard HF; Oxenius A
J Immunol; 2015 Jan; 194(2):637-49. PubMed ID: 25472996
[TBL] [Abstract][Full Text] [Related]
4. The effect of a single amino acid substitution within the V3 loop of HIV-1 gp120 on HLA-DR1-restricted CD4 T-cell recognition.
Fernandez MH; Faith A; Higgins JA; Weber J; Rees AD
Immunology; 1995 Jun; 85(2):176-83. PubMed ID: 7642208
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells from HIV-1-infected patients naturally express HIV-1 gp120 V3 loop-derived peptide ligands.
Fernandez MH; Pitman RJ; Hawrylowicz CM; Rees AD
Eur J Immunol; 1998 Oct; 28(10):3144-53. PubMed ID: 9808183
[TBL] [Abstract][Full Text] [Related]
6. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
[TBL] [Abstract][Full Text] [Related]
7. HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.
García-Arriaza J; Perdiguero B; Heeney JL; Seaman MS; Montefiori DC; Yates NL; Tomaras GD; Ferrari G; Foulds KE; Roederer M; Self SG; Borate B; Gottardo R; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo AD; Weiss DE; Lee C; Kibler KV; Jacobs BL; Wagner R; Ding S; Pantaleo G; Esteban M
J Virol; 2017 May; 91(9):. PubMed ID: 28179536
[TBL] [Abstract][Full Text] [Related]
8. An early antigen-presenting cell defect in HIV-1-infected patients correlates with CD4 dependency in human T-cell clones.
Fidler SJ; Dorrell L; Ball S; Lombardi G; Weber J; Hawrylowicz C; Rees AD
Immunology; 1996 Sep; 89(1):46-53. PubMed ID: 8911139
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine.
Shen X; Basu R; Sawant S; Beaumont D; Kwa SF; LaBranche C; Seaton KE; Yates NL; Montefiori DC; Ferrari G; Wyatt LS; Moss B; Alam SM; Haynes BF; Tomaras GD; Robinson HL
J Virol; 2017 Dec; 91(24):. PubMed ID: 29021394
[TBL] [Abstract][Full Text] [Related]
10. Characterization of antibodies that inhibit HIV gp120 antigen processing and presentation.
Tuen M; Visciano ML; Chien PC; Cohen S; Chen PD; Robinson J; He Y; Pinter A; Gorny MK; Hioe CE
Eur J Immunol; 2005 Sep; 35(9):2541-51. PubMed ID: 16106369
[TBL] [Abstract][Full Text] [Related]
11. Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor.
Callahan KM; Fort MM; Obah EA; Reinherz EL; Siliciano RF
J Immunol; 1990 May; 144(9):3341-6. PubMed ID: 1970352
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD4-binding domain antibodies complexed with HIV type 1 glycoprotein 120 inhibit CD4+ T cell-proliferative responses to glycoprotein 120.
Hioe CE; Jones GJ; Rees AD; Ratto-Kim S; Birx D; Münz C; Gorny MK; Tuen M; Zolla-Pazner S
AIDS Res Hum Retroviruses; 2000 Jun; 16(9):893-905. PubMed ID: 10875615
[TBL] [Abstract][Full Text] [Related]
13. Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gp120 and gp120-specific antibodies from AIDS patients.
Wang ZQ; Orlikowsky T; Dudhane A; Mittler R; Blum M; Lacy E; Riethmüller G; Hoffmann MK
Eur J Immunol; 1994 Jul; 24(7):1553-7. PubMed ID: 7913036
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120.
Hioe CE; Tuen M; Chien PC; Jones G; Ratto-Kim S; Norris PJ; Moretto WJ; Nixon DF; Gorny MK; Zolla-Pazner S
J Virol; 2001 Nov; 75(22):10950-7. PubMed ID: 11602735
[TBL] [Abstract][Full Text] [Related]
15. HLA homology within the C5 domain promotes peptide binding by HIV type 1 gp120.
Cadogan M; Austen B; Heeney JL; Dalgleish AG
AIDS Res Hum Retroviruses; 2008 Jun; 24(6):845-55. PubMed ID: 18544021
[TBL] [Abstract][Full Text] [Related]
16. Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor.
Peachman KK; Karasavvas N; Chenine AL; McLinden R; Rerks-Ngarm S; Jaranit K; Nitayaphan S; Pitisuttithum P; Tovanabutra S; Zolla-Pazner S; Michael NL; Kim JH; Alving CR; Rao M
PLoS One; 2015; 10(12):e0143895. PubMed ID: 26625359
[TBL] [Abstract][Full Text] [Related]
17. The role of complement and gp120-specific antibodies in virus lysis and CD4+ T cell depletion in HIV-1-infected patients.
Gerencer M; Burek V; Crowe BA; Barrett NP; Dorner F
Microb Pathog; 1998 Nov; 25(5):253-66. PubMed ID: 9878454
[TBL] [Abstract][Full Text] [Related]
18. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.
Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S
AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: JAK3 activation and rescue of T cells from HIV gp120-induced unresponsiveness.
Selliah N; Finkel TH
J Immunol; 1998 Jun; 160(12):5697-701. PubMed ID: 9637477
[TBL] [Abstract][Full Text] [Related]
20. A gp120 HIV peptide with high similarity to HLA class II beta chains enhances PPD-specific and autoreactive T cell activation.
Pugliese O; Viora M; Camponeschi B; Cordiali Fei P; Caprilli F; Chersi A; Evangelista M; Di Massimo AM; Colizzi V
Clin Exp Immunol; 1992 Nov; 90(2):170-4. PubMed ID: 1424270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
